Life ScienceCompany
Acorda Therapeutics M&A Summary
Acorda Therapeutics has acquired 4 companies. A total of 1 acquisition came from private equity firms. It has also divested 2 assets.
Acorda Therapeutics’ largest acquisition to date was in 2014, when it acquired Civitas Therapeutics for $525M. Acorda Therapeutics has acquired in 3 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).
Acorda Therapeutics Business Overview
Where is Acorda Therapeutics headquartered?
Acorda Therapeutics is headquartered in Pearl River, New York.
What is Acorda Therapeutics’ revenue?
Acorda Therapeutics disclosed revenue of 118M USD for 2023 and 119M USD for 2022.
How many employees does Acorda Therapeutics have?
Acorda Therapeutics has 102 employees.
What sector is Acorda Therapeutics in?
Acorda Therapeutics is a life science company.
When was Acorda Therapeutics founded?
Acorda Therapeutics was founded in 1995.
M&A Summary
-
M&A Total Activity6
- M&A Buy Activity4
- M&A Sell Activity2
- Total Sectors Invested 1
- Total Countries Invested 2
- M&A Buy/Sell Connections 3
- M&A Advisors 8